Evaluation of a self-administered oral glucose tolerance test

Diabetes Care

Volumn 36, Issue 6, 2013, Pages 1483-1488

  Bethel, M Angelyn ^a,b   Price, Hermione C ^a,b   Sourij, Harald ^a   White, Sarah ^a   Coleman, Ruth L ^a   Ring, Arne ^a,b   Kennedy, Irene E C ^a,b   Tucker, Lynne ^a,b   Holman, Rury R ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; BLOOD SAMPLING; CAPILLARY BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; EQUIPMENT FAILURE; FEASIBILITY STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; HUMAN; LABORATORY DEVICE; LABORATORY TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; VENOUS BLOOD; VOLUNTEER;

AGED; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; SELF ADMINISTRATION;

EID: 84878215863     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-0643     Document Type: Article

References (18)

1. Kahn R, Alperin P, Eddy D, Borch-Johnsen K, Buse J, Feigelman J, et al. Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis. Lancet 2010;375:1365-1374
2. Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, et al. Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess 2007;11:iii-iv, ix-xi, 1-125
3. Buckingham B, Beck RW, Tamborlane WV, Xing D, Kollman C, Fiallo-Scharer R, et al. Continuous glucose monitoring in children with type 1 diabetes. J Pediatr 2007;151:388-393, 93e1-e2
4. Barnhart HX, Haber MJ, Lin LI. An overview on assessing agreement with continuous measurements. J Biopharm Stat 2007;17:529-569 (Pubitemid 47027007)
5. Willavize SA, Morgenthien EA. Comparison of models for average bioequivalence in replicated crossover designs. Pharma Stat 2006;5:201-211 (Pubitemid 44400219)
6. Bland JM, Altman DG. Agreement between methods of measurement with multiple observations per individual. J Biopharm Stat 2007;17:571-582 (Pubitemid 47027010)
7. Mooy JM, Grootenhuis PA, de Vries H, et al. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 1996;39:298-305 (Pubitemid 26066801)
8. Utzschneider KM, Prigeon RL, Tong J, Gerchman F, Carr DB, Zraika S, et al. Within-subject variability of measures of beta cell function derived from a 2 h OGTT: implications for research studies. Diabetologia 2007;50:2516-2525 (Pubitemid 350060640)
9. Crandall JP, Knowler WC, Kahn SE, Marrero D, Florez JC, Bray GA, et al. The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab 2008;4:382-393 (Pubitemid 351881862)
10. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-1589
11. Echouffo-Tcheugui JB, Ali MK, Griffin SJ, Narayan KM. Screening for type 2 diabetes and dysglycemia. Epidemiol Rev 2011;33:63-87
12. Standards of medical care in diabetes - 2012. Diabetes Care 2012;35(Suppl. 1):S11-S63
13. Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007;28:88-136 (Pubitemid 46137814)
14. International Expert Committee. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-1334
15. Khunti K, Gillies CL, Taub NA, Mostafa SA, Hiles SL, Abrams KR, et al. A comparison of cost per case detected of screening strategies for type 2 diabetes and impaired glucose regulation: Modelling study. Diabetes Res Clin Pract 2012;97:505-513
16. Werner EF, Pettker CM, Zuckerwise L, Reel M, Funai EF, Henderson J, et al. Screening for gestational diabetes mellitus: are the criteria proposed by the international association of the Diabetes and Pregnancy Study Groups cost-effective? Diabetes Care 2012;35:529-535
17. Wilson N, Ashawesh K, Smith S, Anwar A. The cost of screening for gestational diabetes mellitus. J Med Screening 2008;15:213
18. Bethel MA, Sourij H. Impact of FDA guidance for developing diabetes drugs on trial design: from policy to practice. Curr Cardiol Rep 2012;14:59-69